ANTIHYPERURICEMIA ACTIVITY OF THE ETHANOL EXTRACT OF ROSELLE CALYX AND ITS FRACTION (HIBISCUS SABDARIFFA LINN) ON MALE WISTAR RATS
Objective: The objective of this study was to determine anti-hyperuricemia activity of ethanol extract of roselle calyx (Hibiscus sabdariffa L) and its fraction on male Wistar rats.
Methods: Two different methods were used. First method induction was done by giving potassium oxonate and diet high purine whereas allopurinol as a comparison. The parameter was level uric acid in serum (uricostatic activity). Second methods induction was done by giving potassium oxonate intraperitoneally and sodium urate orally; with pprobenecid as comparison Parameters used were uric acid level in serum and urine (uricosuric activity).
Results: Ethanol extract roselle calyx at a dose of 40 mg/kg bw, water fraction at a dose of 37.5 mg/kg bw and ethyl acetate fraction at a dose of 6.25 mg/kg bw at day 14 showed a significant reduction in serum uric acid level compared to control group (p<0.05). Besides that ethanol extract of Roselle calyx at dose 80 mg/kg bw, water fraction at doses 37.5 and 75 mg/kg bw also ethyl acetate at doses 6.25 and 12.5 mg/kg bw had uricosuric effect that increased the excretion of uric acid in urine significantly compared to control group (p<0.05).
Conclusion: The water fraction of roselle calyx at doses 37.5 and 75 mg/kg bw and ethyl acetate at dose 6.25 and 12.5 mg/kg bw was effective as an anti-hyperuricemic agent. The ethanol extract of rosele calyx and its fraction had a uricosuric effect similar to probenecid. The best uricosuric effect was showed by ethyl acetate fraction at dose 6.25 mg/kg bw.
Keywords: Hibiscus sabdariffa Linn, Water fraction, Ethyl acetate fraction, Calyx, Uric acid, Antihyperuricemia
2. Kambayana G, Putra TR. Hyperuricemia and related in balinese population. Int J Rheum Dis 2010;13:211-20.
3. Wallace KL, Riedel A, Ridge NJ, Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 y among older adults in a managed care population. J Rheumatol 2004;31:8.
4. Dipiro JT, Talbert RL, Yee GC, Matzke G, Weel B, Possey LM. Pharmacotherapy: a pathophysiologic approach. 7 th ed. NewYork, Mc Graw Hill; 2008.
5. Zhao X, Zhu X, Pan Y. Effects of cassia oil on serum and hepatic uric acid levels in oxonate-induced mice and xanthin dehydrogenase and xanthine oxidase activities in mouse liver. J Ethnopharmacol 2006;103:357-65.
6. Widiyanto PS, Nelistya A. Rosela aneka olahan, Khasiat dan Ramuan, Penebar Swadaya; 2009. p. 11-4, 21.
7. Vogel GH, Drug discovery and evaluation, pharmacological essays. 2nd edition. Springer-Verlag-Berlin-New York; 2002. p. 339-49.
8. Yonetani Y, Iwaki K. Effects of uricosuric drug and diuretics on uric acid excretion in oxonate-treated rats. Jpn J Pharmacol 1983;33:947-57.
9. Afrianti LH, Sukandar EY, Adriyana IK, Ibrahim S. Antihiperuricemic activity of ethyl acetate and ethanol extract of snake fruit var bongkok (Salaca edulis Reinw) on wistar rat. J Teknol Dan Industry Pangan 2011;22:7-10.
10. Oxada Y, Tsuchimoto M, Fukushuma H, Takashi K, Kondo S, Hasegawa M. Hyperuricemic of the novel xanthine oxidase inhibitor, TEI-6720, in Rodent. Eur J Pharmacol 1993,241:183-8.
11. Ni Luh Putu NADW, Efek Asupan Emping Goreng (produk olahan melinjo) terhadap Kadar asam urat darah Laki laki dewasa; 2009.
12. Sugino H, Shimada H. The uricosuric effect in rats of E5050 a new derivate of ethanolamine, involves inhibition of the tubular post-secretory reabsorption of urate. Jpn J Pharmacol 1995;68:297-303.
13. Yu Z, Fong WP, Cheng CHK. The dual actions of morin (3,5,7,2, 4â€“Pentahydroxyflavone) as a hypouricemic agent: uricosuric effect and xanthine oxidase inhibitory activity. J Pharmacol Exp Ther 2005;316:169-75.
14. Huang CG, ShangYJ, Zhang J, Zang JR. Hypouricemic effects of phenylpropanoid glycosides acetonide of Scrophularia ningpoensis on serum uric acid levels in potassium oxonateâ€“pretreated mice. Am J Chin Med 2008;36:149-57.
15. Murugaiyah V, Chans KL. Mechanisms of the anti hyperuricemic effect of Phylantus niruri and its ligands constituents. Ethnopharm 2009;124:233-9.